McKesson Corp (MCK) stock
Close on Nov 11, 2026Market cap $125.89BP/E 27.8Yield 0.29%
McKesson Corp grew revenue 8.2% to $418.79B over the twelve months to Sep 30, 2026. Operating income rose 27.3% to $6.69B, moving the operating margin from 1.4% to 1.6%. Free cash flow was $7.11B, up 11.8% from a year earlier. At the latest close the market valued the company at $125.89B, 27.8 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $125.89B
- P/E ratio
- 27.8
- Price to sales
- 0.30
- Price to book
- –
- Dividend yield
- 0.29%
- Free cash flow yield
- 5.65%
Fundamentals
- Revenue
- $418.79B
- Net income
- $4.70B
- EPS, diluted
- $38.87
- Free cash flow
- $7.11B
- Book value per share
- -$33.88
- Diluted shares
- 117M
Trading
- Next earnings
- Feb 3, 2027 (estimated, after the close)
- Previous close
- $1082.59
- Open
- $1075.23
- Day's range
- $1067.38 – $1081.47
- Volume
- 474,899
- Average volume (20 days)
- 726,176
- Index membership
- S&P 500, Russell 1000, Russell 3000
- Beta (5 years)
- 0.30
- 52-week range
- $723.68 – $1121.50
- RSI (14 days)
- 72.1
- Volatility (1 year)
- 31.7%
- Relative volume
- 0.54×
- WACC
- 7.1%
On 2 of our idea lists: Dividend growers, Buyback cannibals
Index membership is inferred from the holdings of funds that track each index (VOO, IVV, SPYM, IWB, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2009, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | MCK | S&P 500 | Difference | MCK per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +15.0% | -2.4% | +17.4 pts | ||
| 3 months | +19.9% | -1.2% | +21.0 pts | ||
| Year to date | +32.0% | +12.3% | +19.7 pts | ||
| 1 year | +26.6% | +12.4% | +14.1 pts | ||
| 3 years | +133.2% | +78.8% | +54.4 pts | +32.6% | +21.4% |
| 5 years | +397.2% | +75.2% | +322.0 pts | +37.8% | +11.9% |
| 10 years | +714.6% | +311.1% | +403.5 pts | +23.3% | +15.2% |
Fifteen years at a glance
Fiscal years 2012 to 2026 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases McKesson filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Results
- Results
- Update
- Results
About McKesson
Wholesale-Drugs, Proprietaries & Druggists' Sundries
McKesson Corporation is an enterprise involved in healthcare distribution and support services. Operating across distinct operating segments including North American Pharmaceutical, Medical-Surgical Solutions, Oncology and Multispecialty, and Prescription Technology Solutions, the company supplies pharmaceuticals, medical-surgical products, and specialized technology infrastructure. Its operations serve broad healthcare customers through established provider networks, distribution channels, and integrated care solutions across multiple clinical disciplines.
Company profile, executives and historyMcKesson stock: common questions
What is McKesson's stock price?
MCK closed at $1079.79 on Nov 11, 2026, down 0.26% on the day. Over the past 52 weeks it traded between $723.68 and $1121.50.
What is McKesson's market cap?
McKesson was worth $125.89B at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is MCK's P/E ratio?
MCK trades at 27.8 times earnings, based on diluted earnings per share of $38.87 over the twelve months to Sep 30, 2026.
How much revenue does McKesson make?
McKesson reported revenue of $418.79B for the twelve months to Sep 30, 2026, up 8.2% from a year earlier.
Does McKesson pay a dividend?
Yes. McKesson paid $3.17 per share over the last twelve months, a yield of 0.29% at the latest price, and has raised its annual dividend 13 years in a row.
When does McKesson report earnings next?
McKesson is expected to report Q3 FY2027 results on Feb 3, 2027, after the close. The date is estimated from its past reporting pattern until the company confirms it.
How has MCK stock performed over the past year?
Including dividends, MCK returned +26.6% over the past year, against +12.4% for the S&P 500.
How many MCK shares are sold short?
2M shares were sold short at the latest FINRA report, 1.71% of the float, or 2.9 days of average trading volume.
Who are McKesson's competitors?
Companies most similar to McKesson by business, industry and size include CAH, COR, UNH, CVS, CI.
See a number that looks wrong?